However, EMMPRIN has been demonstrated to inhibit TNF-induced apoptosis and the NF-kB-dependent proinflammatory cytokines secretion in synovial tissue during RA (Zhai et al., 2016). This evidence concerns the gene TNF and rheumatoid arthritis.